Clinical Trials Directory

Trials / Completed

CompletedNCT04977440

High Protein Intake in Critically Ill Ventilated Patients

High Protein Intake During the Early Phase of Critical Illness Compared With Normal Protein Intake

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This prospective interventional randomized control study was conducted on forty patients with respiratory failure; all patients were intubated and mechanically ventilated for at least three days. Twenty patients received high protein intake using whey protein, with daily follow-up of the blood sugar level, serum electrolytes, and chemistry. ICU outcome regarding food intolerance, 30-day mortality, length of MV and ICU-stay was recorded

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWhey proteinPatients were randomly divided into two groups: Group (A): Enteral feeding with normal protein intake ( 1.0 gm pin /kg/day ) Group (B): Enteral feeding with high protein intake ( 1.5- gm open /kg/day ) -Patient's- nonprotein- caloric intake was calculated according to REE :(25xactual body weight in kg ) and received it as follow : 1/2 the calculated amount of caloric intake in DAY 1 3/4 of the calculated amount of caloric intake in DAY 2 -Full calculated caloric amount in DAY 3 This regimen was followed long as the patient was tolerating the amount of feeding, and in case of intolerance: The volume of feeding boluses was decreased or Increase the time interval between boluses or IV metoclopramide or erythromycin was given

Timeline

Start date
2020-01-01
Primary completion
2020-12-31
Completion
2021-02-01
First posted
2021-07-27
Last updated
2021-07-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04977440. Inclusion in this directory is not an endorsement.